ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

CXCL13 variant predicts pegylated-interferon a treatment response in HBeAg-positive chronic hepatitis B patients

Luo, Mengqi; Zhang, Lingyan; Yang, Chou; Zhou, Bin; Hou, Jinlin*; Jiang, De-Ke*南方医科大学
Journal of Medical Virology2023-7DOI: 10.1002/jmv.28963
5阅读
引用收藏
分享

摘要

As a key immune cytokine, C-X-C motif chemokine ligand 13 (CXCL13) has been reported to play critical roles in immune control of hepatitis B virus (HBV) infection. We aimed to screen single-nucleotide polymorphisms (SNPs) of CXCL13 for predicting response to pegylated interferon-alpha (PegIFNa) therapy of chronic hepatitis B (CHB) patients. Two independent cohorts with a total of 945 (Cohort 1, n = 238; Cohort 2, n = 707) hepatitis B e antigen (HBeAg)-positive CHB patients treated with PegIFNa were enrolled in this retrospective cohort study. Eight candidate SNPs were selected through gene-wide SNP mining within or flanking CXCL13. A polygenic score (PGS) was utilized to assess the cumulative effects of multiple SNPs. The associations of candidate SNPs and PGS with combined response (CR, defined as the combination of HBeAg seroconversion and HBV DNA level <3.3log(10) IU/mL) and hepatitis B surface antigen (HBsAg) level were evaluated. Among the eight candidate SNPs, rs76084459 which is located at upstream of CXCL13 was significantly associated with both CR (p = 0.002) and HBsAg level (p = 0.015). A PGS integrating CXCL13_rs76084459 and five other SNPs, which were previously identified as predictors of PegIFNa treatment response, was further strongly correlated with CR (p = 1.759 x 10(-10)) and HBsAg level (p = 0.004). This study demonstrated that CXCL13_rs76084459 can predict response to PegIFNa treatment of HBeAg-positive CHB patients. A PGS composed of six SNPs including CXCL13_rs76084459 predicts PegIFNa treatment response better.

学科与关键词

关键词
chronic hepatitis B (CHB)C-X-C motif chemokine ligand 13 (CXCL13)hepatitis B virus (HBV)pegylated interferon-alpha (PegIFN & alpha)single-nucleotide polymorphism (SNP)
相关
加载中…
  • An intronic genetic variant of ZHX2 predicts response to pegylated interferon α therapy in HBeAg-positive chronic hepatitis B patients
    Hou, Jia; Dong, Chao; Chen, Jiaxuan; Chen, Haitao; Na, Rong; Zhou, Bin; Hou, Jinlin*; Jiang, De-Ke*Antiviral Research, 2023, 220: 105741.
  • CD55 Variant Associated with Pegylated-interferon α Therapy Response in HBeAg-positive Chronic Hepatitis B Patients
    Chen, Jiaxuan; Lou, Shuang; Chen, Haitao; Zhou, Bin; Sun, Jian; Hou, Jinlin; Jiang, De-Ke*Journal of Clinical and Translational Hepatology, 2022, 11(2): 295-303.被引 3
  • A Missense Variant in Granulysin is Associated with the Efficacy of Pegylated-Interferon-Alpha Therapy in Chinese Patients with HBeAg-Positive Chronic Hepatitis B
    Li, Jing; Chen, Haitao; Chen, Jiaxuan; Zhou, Bin; Hou, Jinlin*; Jiang, De-Ke*Pharmacogenomics and Personalized Medicine, 2021, 14: 1505-1515.被引 5
查看全部 →

发表信息

论文状态
公开发表
期刊
Journal of Medical Virology
发表日期
2023-07
卷期
第 95 卷, 第 7 期
页码
e28963
DOI
10.1002/jmv.28963
语言
ENGLISH
成果收录
SCIE
资助标注
National Key Research and Development Program of China [2022YFC2303600]; National Natural Science Foundation of China [82272765, 81670535, 81472618]; Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program [2017BT01S131]; Natural Science Foundation of Guangdong Province [2022A1515220090, 2019A1515011423]; Innovative Research Team Project of Guangxi Province [2017GXNSFGA198002]; Outstanding Youth Development Scheme of Nanfang Hospital, Southern Medical University [2017J001]; Grant for Recruited Talents to Start Scientific Research from Nanfang Hospital

作者

  • L

    Luo, Mengqi (第一作者)

    southern med univ · youjiang med univ nationalities

  • Z

    Zhang, Lingyan

    southern med univ

查看全部 6 位作者收起作者
  • Y

    Yang, Chou

    southern med univ

  • Z

    Zhou, Bin

    southern med univ

  • H

    Hou, Jinlin (通讯)

    southern med univ

  • J

    Jiang, De-Ke (通讯)

    southern med univ · youjiang med univ nationalities

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417